Lori F. Rafield
Chief Executive Officer at LFR Advisors, Inc.
Profile
Lori F.
Rafield is the Chief Executive Officer of LFR Advisors, Inc. She was previously the Chairman & Chief Executive Officer of Diadexus, Inc. from 2015 to 2016 and a Director at VaxGen, Inc. from 2008 to 2010.
She also served as a Director at diaDexus, Inc. and was a Partner at Apax Partners, Inc. from 2004 to 2005.
Rafield received her undergraduate degree from The Pennsylvania State University and her doctorate from The University of Virginia School of Medicine in 1981.
Lori F. Rafield active positions
| Companies | Position | Start |
|---|---|---|
| LFR Advisors, Inc. | Chief Executive Officer | 2005-12-31 |
Former positions of Lori F. Rafield
| Companies | Position | End |
|---|---|---|
| DIADEXUS, INC. | Chief Executive Officer | 2015-12-31 |
diaDexus, Inc. /Old/
 diaDexus, Inc. /Old/ Medical SpecialtiesHealth Technology diaDexus is a privately held biotechnology company that is focused on the discovery, development and commercialization of novel, patent protected diagnostic products with high clinical value. diaDexus makes a difference by developing innovative products with clinical value to address significant unmet medical needs in the cardiovascular field. | Director/Board Member | 2010-10-31 |
VaxGen, Inc.
 VaxGen, Inc. BiotechnologyHealth Technology VaxGen, Inc. is a biopharmaceutical company, owns a state-of-the-art biopharmaceutical manufacturing facility that can be used to make cell culture or microbial biologic products. The company has ended all product development activities and sold or otherwise terminated its drug development programs. It is seeking to maximize the value of its remaining tangible and intangible assets through a transaction or series of transactions, including the sale of the manufacturing facility. The company was founded on November 01, 1995 and is headquartered in South San Francisco, CA. | Director/Board Member | 2010-10-31 |
Apax Partners, Inc.
 Apax Partners, Inc. Investment ManagersFinance Founded in 1976, Apax Partners, Inc. is a venture capital/private equity firm located in New York City. The firm is a subsidiary of London-based Apax Partners LLP | Private Equity Investor | 2005-06-05 |
Training of Lori F. Rafield
| The Pennsylvania State University | Undergraduate Degree |
| The University of Virginia School of Medicine | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Apax Partners, Inc.
Apax Partners, Inc. Investment ManagersFinance Founded in 1976, Apax Partners, Inc. is a venture capital/private equity firm located in New York City. The firm is a subsidiary of London-based Apax Partners LLP | Finance |
VaxGen, Inc.
VaxGen, Inc. BiotechnologyHealth Technology VaxGen, Inc. is a biopharmaceutical company, owns a state-of-the-art biopharmaceutical manufacturing facility that can be used to make cell culture or microbial biologic products. The company has ended all product development activities and sold or otherwise terminated its drug development programs. It is seeking to maximize the value of its remaining tangible and intangible assets through a transaction or series of transactions, including the sale of the manufacturing facility. The company was founded on November 01, 1995 and is headquartered in South San Francisco, CA. | Health Technology |
diaDexus, Inc. /Old/
diaDexus, Inc. /Old/ Medical SpecialtiesHealth Technology diaDexus is a privately held biotechnology company that is focused on the discovery, development and commercialization of novel, patent protected diagnostic products with high clinical value. diaDexus makes a difference by developing innovative products with clinical value to address significant unmet medical needs in the cardiovascular field. | Health Technology |
Diadexus, Inc.
 Diadexus, Inc. BiotechnologyHealth Technology Diadexus, Inc. engages in the research, development, and commercialization of pharmaceutical products. Its portfolio intends to treat cardiovascular diseases. The company was founded on November 27, 1995 and is headquartered in South San Francisco, CA. | Health Technology |
| LFR Advisors, Inc. |
- Stock Market
- Insiders
- Lori F. Rafield
